ArticleRespiratory medicine case reports2026
Extranodal marginal zone lymphoma presenting as a paraspinal mass and pleural effusion.
Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MALT-lymphomas are a subtype of non-Hodgkin lymphomas that typically present in the gastro-intestinal tract (50% of cases), the salivary glands and lung. Pleural involvement, however, is exceedingly rare with only a few cases described in the literature to date. Here we present a case of pleural MALT-lymphoma in a 71-year-old woman presenting with progressive dyspnea since 5-6 months without cough or sputum. The CT scan showed paravertebral bilateral pleural thickening (right > left), with associated right sided pleural effusion. Positron emission tomography (PET) scan revealed FDG-uptake limited to the thickened areas of the pleura. Pleural fluid analysis was consistent with a pleural exudate with marked predominance of lymphocytes on flow cytometry (93% lymphocytes) with negative aerobic, anaerobic and mycobacterial cultures. A thoracoscopic biopsy of the right pleural mass revealed massive invasion of the pleura by a mucosa-associated lymphoid tissue lymphoma. The final diagnosis was a stage IV MALT-lymphoma for which systemic therapy with rituximab-bendamustine was administered. Follow-up FDG-PET-CT scan after 4 chemotherapy cycles confirmed complete radiological remission. The case is particularly remarkable because there was no known pre-existing pleural inflammation, which is typically a hallmark of MALT lymphoma in extranodal sites. Immunohistochemical characterization of pleural fluid lymphocyte subtypes might have provided a clue to the diagnosis. In pleural exudates with lymphocytic predominance this diagnostic step should not be overlooked.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.